Cargando…
Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection
COVID-19 exhibits a global health threat among the elderly and the population with underlying health conditions. During infection, the host's innate immune response acts as a frontline of defense by releasing cytokines such as type I interferon (IFN α and β) thereby initiating antiviral activit...
Autores principales: | Kali, Suresh Kumar, Dröge, Peter, Murugan, Priyatharshini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302486/ https://www.ncbi.nlm.nih.gov/pubmed/34311016 http://dx.doi.org/10.1016/j.micpath.2021.105105 |
Ejemplares similares
-
Innate immune recognition against SARS-CoV-2
por: Yamada, Taisho, et al.
Publicado: (2023) -
Evolution of enhanced innate immune evasion by SARS-CoV-2
por: Thorne, Lucy G., et al.
Publicado: (2021) -
Devil's tools: SARS-CoV-2 antagonists against innate immunity
por: Xu, Duo, et al.
Publicado: (2021) -
TLRs: Innate Immune Sentries against SARS-CoV-2 Infection
por: Mantovani, Stefania, et al.
Publicado: (2023) -
SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3
por: Freitas, Raul S., et al.
Publicado: (2022)